富士製薬工業(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 医薬品 | 4554/E00975 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2019/12/06 | 日証協 | 61,551株 | -16.43% | 48,956株 | -36.86% | 92,516株 | -0.7% | 15,200株 | -62.65% |
2019/11/29 | 日証協 | 73,651株 | -0.01% | 77,539株 | -21.28% | 93,172株 | -8.63% | 40,700株 | +40.32% |
2019/11/22 | 日証協 | 73,656株 | -16.45% | 98,505株 | +17.55% | 101,972株 | -17.35% | 29,005株 | -17.6% |
2019/11/15 | 日証協 | 88,156株 | +15.46% | 83,800株 | +68.12% | 123,372株 | +3.17% | 35,200株 | +179.34% |
2019/11/08 | 日証協 | 76,351株 | +15.41% | 49,846株 | +36.56% | 119,578株 | -10.68% | 12,601株 | +28.52% |
2019/11/01 | 日証協 | 66,156株 | +10.71% | 36,500株 | +241.22% | 133,877株 | +1.83% | 9,805株 | +510.9% |
2019/10/25 | 日証協 | 59,756株 | +62.57% | 10,697株 | -61.8% | 131,477株 | +25.25% | 1,605株 | -94.87% |
2019/10/18 | 日証協 | 36,756株 | +11.87% | 28,000株 | +59.12% | 104,974株 | +8.68% | 31,283株 | +108.66% |
2019/10/11 | 日証協 | 32,856株 | +13.08% | 17,597株 | -69.7% | 96,594株 | +6.31% | 14,992株 | -56.03% |
2019/10/04 | 日証協 | 29,056株 | +116.84% | 58,069株 | +432.74% | 90,859株 | +11.69% | 34,097株 | +75.46% |
2019/09/27 | 日証協 | 13,400株 | -58.13% | 10,900株 | +11.16% | 81,349株 | -18.24% | 19,433株 | +118.35% |
2019/09/20 | 日証協 | 32,006株 | -51.03% | 9,806株 | -67.53% | 99,503株 | -34.37% | 8,900株 | -69.37% |
2019/09/13 | 日証協 | 65,364株 | +13.35% | 30,200株 | +68.75% | 151,623株 | +11.44% | 29,058株 | +233.62% |
2019/09/06 | 日証協 | 57,664株 | -6.7% | 17,896株 | +19.21% | 136,059株 | -1.32% | 8,710株 | -44.48% |
2019/08/30 | 日証協 | 61,806株 | -4.32% | 15,012株 | +117.57% | 137,879株 | -2.48% | 15,688株 | +56.5% |
2019/08/23 | 日証協 | 64,594株 | -5.24% | 6,900株 | +91.67% | 141,379株 | +2.89% | 10,024株 | +82.45% |
2019/08/16 | 日証協 | 68,164株 | -7.59% | 3,600株 | -65.4% | 137,413株 | -1.29% | 5,494株 | -77.93% |
2019/08/09 | 日証協 | 73,764株 | -4.01% | 10,406株 | +96.34% | 139,213株 | +17.57% | 24,894株 | +329.21% |
2019/08/02 | 日証協 | 76,842株 | -1.59% | 5,300株 | -23.26% | 118,413株 | +2.35% | 5,800株 | -31% |
※株式分割は考慮していませんのでご注意ください。
Page Top